IRD
Opus Genetics
IRD
IRD
35 hedge funds and large institutions have $10.8M invested in Opus Genetics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
5% less funds holding
Funds holding: 37 → 35 (-2)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Holders
35
Holding in Top 10
1
Calls
$35K
Puts
$28K
Top Buyers
| 1 | +$938K | |
| 2 | +$293K | |
| 3 | +$134K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$75.8K |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
+$58.1K |
Top Sellers
| 1 | -$61.4K | |
| 2 | -$60K | |
| 3 | -$49K | |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$42K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$39K |